HIV medications stop the virus from making copies of itself. The Food and Drug Administration (FDA) has approved more than 50 HIV medications. HIV is transmitted through contact with blood, semen ...

Injectable HIV therapy offers hope for those who struggle with daily pills—providing a powerful, long-lasting alternative to ...

These inhibitors can interfere with the HIV capsid at various stages of the viral life cycle. Fixed-dose combination drugs reduce the daily pill burden a person with HIV may otherwise be faced ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...

HIV conference opened in San Francisco Sunday, March 9, under a cloud of uncertainty in the face of the Trump ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...